Role of Defective Apoptosis in Type 1 Diabetes and Other Autoimmune Diseases

Recent Progress in Hormone Research

Volumn 58, Issue , 2003, Pages 131-153

  Hayashi, Takuma ^a   Faustman, Denise L ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; FAS ANTIGEN; FAS LIGAND; GRANULOCYTE COLONY STIMULATING FACTOR; HLA ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEASOME; PROTEIN LMP2; PROTEIN SUBUNIT; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA; UBIQUITIN; UNCLASSIFIED DRUG; CYSTEINE PROTEINASE; LMP 2 PROTEIN; LMP-2 PROTEIN; MULTIENZYME COMPLEX;

AGE; ANIMAL MODEL; ANTIGEN PRESENTING CELL; APOPTOSIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELL PROTECTION; CELL SELECTION; COLONY FORMING UNIT GM; CONTROLLED STUDY; CYTOTOXICITY; ENHANCER REGION; GENDER; GENE EXPRESSION; GENE MUTATION; GENETIC CODE; GENETIC DISORDER; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOME; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KNOCKOUT MOUSE; LYMPHOCYTE; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; LYMPHOID CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; MOUSE STRAIN; MULTIPLE SCLEROSIS; NONHUMAN; PANCREAS ISLET BETA CELL; PATHOGENESIS; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN PROCESSING; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SPLEEN CELL; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; TISSUE SPECIFICITY; ANIMAL; GENETIC PREDISPOSITION; GENETICS; NONOBESE DIABETIC MOUSE; PATHOLOGY; PHYSIOLOGY;

ANIMALS; APOPTOSIS; AUTOIMMUNE DISEASES; CYSTEINE ENDOPEPTIDASES; DIABETES MELLITUS, TYPE 1; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; MICE; MICE, INBRED NOD; MULTIENZYME COMPLEXES; NF-KAPPA B; PROTEASOME ENDOPEPTIDASE COMPLEX; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0041307005     PISSN: 00799963     EISSN: None     Source Type: Journal    
DOI: 10.1210/rp.58.1.131     Document Type: Review

References (118)

1. Akiyama K, Yokota K, Kagawa S, Shimbara N, Tamura T, Akioka H, Nothwang HG, Noda C, Tanaka K, Ichihara A 1994 cDNA cloning and interferon γ down-regulation of proteasomal subunits X and Y. Science 265:1231-1234
2. + T cells in TAP-1 mutant mice. Proc Natl Acad Sci USA 91:6525-6528
3. Allen RD, Marshall JD, Roths JB, Sidman CL 1990 Differences defined by bone marrow transplantation suggest that lpr and gld are mutations of genes encoding an interacting pair of molecules. J Exp Med 172:1367-1375
4. + T lymphocytes in transgenic nonobese diabetic mice. J Clin Invest 103:1201-1209
5. Atkinson MA, Leiter EH 1999 The NOD mouse model of type I diabetes: as good as it gets? Nat Med 5:601-604
6. Baeuerle PA, Baltimore D 1996 NF-κB: ten years after. Cell 87:13-20
7. Baldwin AS 1996 The NF-κB and IκB proteins: new discoveries and insights. Annu Rev Immunol 12:141-179
8. Becker KG, Simon RM, Bailey-Wilson JE, Freidlin B, Biddison WE, McFarland HF, Trent JM 1998 Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases. Proc Natl Acad Sci USA 95:9979-9984
9. Beg AA, Baltimore D 1996 An essential role for NF-κB in preventing TNF-α-induced cell death. Science 274:782-784
10. Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D 1995 Embryonic lethality and liver degeneration in mice lacking the relA component of NF-κB. Nature 376:167-170
11. Belich MP, Glynne RJ, Senger G, Sheer D, Trowsdale J 1994 Proteasome components with reciprocal expression to that of the MHC-encoded LMP proteins. Curr Biol 4:769-776
12. Belich MP, Salmeron A, Johnston LH, Ley SC 1999 TPL-2 kinase regulates the proteolysis of the NF-κB-inhibitory protein NF-κB1 p105. Nature 397:363-368
13. Bohnline E, Lowenthal JW, Siekevitz M, Franza BR, Greene WC 1988 The same inducible nuclear protein regulates mitogen activation of both the interleukin-2 receptor-α gene and type 1 HIV. Cell 53:827-836
14. Burkly L, Hession C, Ogata L, Reilly C, Marconi LA, Olson D, Tizard R, Cate R, Lo D 1995 Expression of relB is required for the development of thymic medulla and dendritic cells. Nature 373:531-536
15. Bushdid PB, Brantley DM, Yull FE, Blaeuer GL, Hoffman LH, Niswander L, Kerr LD 1998 Inhibition of NF-κB activity results in disruption of the apical ectodermal ridge and aberrant limb morphogenesis. Nature 392:615-618
16. Caamano JH, Rizzo CA, Durham SK, Barton DS, Raventos-Suarez C, Snapper CM, Bravo R 1998 Nuclear factor (NF)-κB2 (p100/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses. J Exp Med 187:185-196
17. Chervonsky AV, Wang Y, Wong FS, Visintin I, Flavell RA, Janeway CA Jr, Matis LA 1997 The role of Fas in autoimmune diabetes. Cell 89:17-24
18. Coux O, Goldberg AL 1998 Enzymes catalyzing ubiquitination and proteolytic processing of the p105 precursor of nuclear factor κB1. J Biol Chem 273:8820-8828
19. Coux O, Tanaka K, Goldberg AL 1996 Structure and functions of the 20S and 26S proteasomes. Annu Rev Biochem 65:801-847
20. Crisa L, Mordes JP, Rossini AA 1992 Autoimmune diabetes mellitus in the BB rat. Diabetes Metab Rev 8:9-37
21. Cross SL, Halden NF, Lenardo M, Leonard WJ 1989 Functionally distinct NF-κB binding sites in the immunoglobulin κ and IL-2 receptor α chain genes. Science 244:466-468
22. Delovitch TL, Singh B 1997 The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD [published erratum appears in Immunity 1998;8:531]. Immunity 7:727-738
23. Delovitch TL, Singh B 1997 The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD [published erratum appears in Immunity 1998;8:531]. Immunity 7:727-738
24. Desai-Mehta A, Lu L, Ramsey-Goldman R, Datta SK 1996 Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production. J Clin Invest 97:2063-2073
25. Drappa J, Vaishnaw AK, Sullivan KE, Chu JL, Elkon KB 1996 Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity [see comments]. N Engl J Med 335:1643-1649
26. Emlen W, Niebur J, Kadera R 1994 Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J Immunol 152:3685-3692.
27. Fan CM, Maniatis T 1991 Generation of p50 subunit of NF-κB by processing of p 105 through an ATP-dependent pathway. Nature 354:395-398
28. Faustman D, Eisenbarth G, Daley J, Breitmeyer J 1989 Abnormal T lymphocyte subsets in type I diabetes mellitus: analysis with anti-2H4 and anti-4B4 antibodies. Diabetes 38:1462-1468
29. Faustman D, Li X, Lin HY, Fu Y, Eisenbarth G, Avruch J, Guo J 1991 Linkage of faulty major histocompatibility complex class I to autoimmune diabetes. Science 254:1756-1761
30. Foulis AK 1987 The pathogenesis of beta cell destruction in type I (insulin-dependent) diabetes mellitus. J Pathol 152:141-148
31. Franzoso G, Carlson L, Xing L, Poljak L, Shores EW, Brown KD, Leonardi A, Tran T, Boyce BF, Siebenlist U 1997 Requirement for NF-κB in osteoclast and B-cell development. Genes Dev 11:3482-3496
32. Freland S, Chambers BJ, Andersson M, Van Kaer L, Ljunggren HG 1998 Rejection of allogeneic and syngeneic but not MHC class I-deficient tumor grafts by MHC class I-deficient mice. J Immunol 160:572-579
33. Fruh K, Yang Y, Arnold D, Chambers J, Wu L, Waters JB, Spies T, Peterson PA 1992 Alternative exon usage and processing of the major histocompatibility complex-encoded proteasome subunits. J Biol Chem 267:22131-22140
34. Fu Y, Nathan DM, Li F, Li X, Faustman DL 1993 Defective major histocompatibility complex class I expression on lymphoid cells in autoimmunity. J Clin Invest 9 1:2301-2307
35. Gaczynska M, Goldberg AL, Tanaka K, Hendil KB, Rock KL 1996 Proteasome subunits X and Y alter peptidase activities in opposite ways to the interferon-γ-induced subunits LMP2 and LMP7. J Biol Chem 27 1:17275-17280
36. Ghosh S, Baltimore D 1990 Activation in vitro of NF-κB by phosphorylation of its inhibitor IκB. Nature 344:678-682
37. + T cell repertoire in β-microglobulin-deficient mice is biased towards reactivity against self-major histocompatibility class I. J Exp Med 179:661-672
38. Goldberg AL 1995 Functions of the proteasome: the lysis at the end of the tunnel [see comment], Science 268:522-523
39. Griffin TA, Nandi D, Cruz M, Fehling HJ, Kaer LV, Monaco JJ, Colbert RA 1998 Immunoproteasome assembly: cooperative incorporation of interferon γ (IFN-γ)-inducible subunits. J Exp Med 187:97-104
40. Hanafusa T, Miyazaki A, Miyagawa J, Tamura S, Inada M, Yamada K, Shinji Y, Katsura H, Yamagata K, Itoh N 1990 Examination of islets in the pancreas biopsy specimens from newly diagnosed type I (insulin-dependent) diabetic patients. Diabetologia 33:105-111
41. Hayashi T, Faustman D 1999 NOD mice are defective in proteasome production and activation of NF-κB. Mol Cell Biol 19:8646-8659
42. Hayashi T, Faustman D 2000 Essential role of HLA-encoded proteasome subunits in NF-κB activation and prevention of TNF-α-induced apoptosis. J Biol Chem 275:5238-5247
43. Hayashi T, Sekine T, Okamoto T 1993a Identification of a new serine kinase that activates NFκB by direct phosphorylation. J Biol Chem 268:26790-26795
44. Hayashi T, Ueno Y, Okamoto T 1993b Oxireductive regulation of nuclear factor κB, involvement of a cellular reducing catalyst thioredoxin. J Biol Chem 268:11380-11388
45. Hayashi T, Kodama S, Faustman D 2000 LMP2 expression and proteasome activity in NOD mice. Nat Med 6:1064-1066
46. Hisamatsu H, Shimbara N, Saito Y, Kristensen P, Hendil KB, Fujiwara T, Takahashi E, Tanahashi N, Tamura T, Ichihara A, Tanaka K 1996 Newly identified pair of proteasomal subunits regulated reciprocally by interferon-γ. J Exp Med 183:1807-1816
47. Horwitz BH, Scott ML, Cherry SR, Bronson RT, Baltimore D 1997 Failure of lymphopoiesis after adoptive transfer of NF-κB-deficient fetal liver cells. Immunity 6:765-772
48. Hsu SC, Gavrilin MA, Lee HH, Wu CC, Han SH, Lai MZ 1999 NF-κB-dependent Fas ligand expression. Eur J Immunol 29:2948-2956
49. Hu Y, Baud V, Delhase M, Zhang P, Deerinck T, Ellisman M, Johnson R, Karin M 1999 Abnormal morphogenesis but intact IKK activation in mice lacking the IKKα subunit of IκB kinase [see comments]. Science 284:316-320
50. Iotsova V, Caamano J, Loy J, Yang Y, Lewin A, Bravo R 1997 Osteopetrosis in mice lacking NF-κ1 and NF-κB2. Nat Med 3:1285-1289
51. Itoh N, Imagawa A, Hanafusa T, Waguri M, Yamamoto K, Iwahashi H, Moriwaki M, Nakajima H, Miyagawa J, Namba M, Makino S, Nagata S, Kono N, Matsuzawa Y 1997 Requirement of Fas for the development of autoimmune diabetes in nonobese diabetic mice. J Exp Med 186:613-618
52. Jansen A, Van Hagen M, Drexhage HA 1995 Defective maturation and function of antigen-presenting cells in type I diabetes. Lancet 345:491-492
53. Kanegae Y, Tavares AT, Izpisua Belmonte JC, Verma IM 1998 Role of Rel/NF-κB transcription factors during the outgrowth of the vertebrate limb. Nature 392:611-614
54. Kang SM, Schneider DB, Lin Z, Hanahan D, Dichek DA, Stock PG, Baekkeskov S 1997 Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction [see conunents], Nat Med 3:738-743
55. Kang SM, Lin Z, Ascher NL, Stock PG 1998 Fas ligand expression on islets as well as multiple cell lines results in accelerated neutrophilic rejection. Transplant Proc 30:538
56. Kay TWH, Campbell IL, Oxbrow L, Harrison LC 1991 Overexpression of class I major histocompatibiity complex accompanies insulitis in the nonobese diabetic mouse and is prevented by anti-interferon-γ antibody. Diabetologia 34:779-785
57. Kim S, Kim KA, Hwang DY, Lee TH, Kayagaki N, Yagita H, Lee MS 2000 Inhibition of autoimmune diabetes by Fas ligand: the paradox is solved. J Immunol 164:2931-2936
58. Kim YH, Kim S, Kim KA, Yagita H, Kayagaki N, Kim KW, Lee MS 1999 Apoptosis of pancreatic beta-cells detected in accelerated diabetes of NOD mice: no role of Fas-Fas ligand interaction in autoimmune diabetes. Eur J Immunol 29:455-465
59. Kontgen F, Grumont RJ, Strasser A, Metcalf D, Li R, Tarlinton D, Gerondakis S 1995 Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev 9:1965-1977
60. Koshy M, Berger D, Crow MK 1996 Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes. J Clin Invest 98:826-837
61. Kovacs B, Liossis SN, Dennis GJ, Tsokos GC 1997 Increased expression of functional Fas-ligand in activated T cells from patients with systemic lupus erythematosus. Autoimmunity 25:213-221
62. Lamhamedi-Cherradi SE, Luan JJ, Eloy L, Fluteau G, Bach JF, Garchon HJ 1998 Resistance of T-cells to apoptosis in autoimmune diabetic (NOD) mice is increased early in life and is associated with dysregulated expression of Bcl-x. Diabetologia 41:178-184
63. Li F, Hauser SL, Linan MJ, Stein MC, Faustman DL 1995 Reduced expression of peplideloaded HLA class I molecules on multiple sclerosis lymphocytes. Ann Neurol 38:147-154
64. Li Q, Lu Q, Hwang JY, Buscher D, Lee KF, Izpisua-Belmonte JC, Verma IM 1999a IKK1 deficient mice exhibit abnormal development of skin and skeleton. Genes Dev 13:1322-1328
65. Li Q, Van Antwerp D, Mercurio F, Lee KF, Verma IM 1999b Severe liver degeneration in mice lacking the IκB kinase 2 gene [see comments]. Science 284:321-325
66. Li X, Faustman D 1993 Use of donor β2-microglobulin-deficient transgenic mouse liver cells for isografts, allografts, and xenografts. Transplantation 55:940-946
67. Liang H, Fesik SW 1997 Three-dimensional structures of proteins involved in programmed cell death. J Mol Biol 274:291-302
68. Lin J, Tserng K, Chen C, Lin L, Tung T 1970 Abrin and ricin: new anti-tumor substances. Nature 227:562-563
69. Lin L, DeMartino GN, Greene WC 1998 Co-translational biogenesis of NF-κB p50 by the 26S proteasome. Cell 92:819-828
70. Lorenz HM, Grunke M, Hieronymus T, Herrmann M, Kuhnel A, Manger B, Kalden JR 1997 In vitro apoptosis and expression of apoptosis-related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases [see comments]. Arthritis Rheum 40:306-317
71. Lynch DH, Watson ML, Alderson MR, Baum PR, Miller RE, Tough T, Gibson M, Davis-Smith T, Smith CA, Hunter K 1994 The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster. Immunity 1:131-136
72. MacKichan ML, Logeat F, Israel A 1996 Phosphorylation of p105 PEST sequences via a redox-insensitive pathway up-regulates processing of p50 NF-κB. J Biol Chem 271:6084-6091
73. Makino S, Kunimoto K, Muraoka Y, Mizushima Y, Katagiri K, Tochino Y 1980 Breeding of a non-obese, diabetic strain of mice. Jikken Dobutsu Exp Animals 29:1-13
74. Maniatis T 1999 A ubiquitin ligase complex essential for the NF-κB, Wnt/Wingless, and Hedgehog signaling pathways. Genes Dev 13:505-510
75. Mountz JD, Zhou T, Su X, Cheng J, Pierson M, Bluethmann H, Edwards CK III 1996 Autoimmune disease results from multiple interactive defects in apoptosis induction molecules and signaling pathways. Behring Inst Mitteilungen 6:200-219
76. Mysler E, Bini P, Drappa J, Ramos P, Friedman SM, Krammer PH, Elkon KB 1994 The apoptosis-1/Fas protein in human systemic lupus erythematosus. J Clin Invest 93:1029-1034
77. Oeri A, Chang CC, Lombardi L, Salina M, Corradini P, Maiolo AT, Chaganti RS, Dalla-Favera R 1991 B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-κB p50. Cell 67:1075-1087
78. Ono SJ, Issa-Chergui B, Colle E, Guttmann RD, Seemayer TA, Fuks A 1988 IDDM in BB rats. Enhanced MHC class I heavy-chain gene expression in pancreatic islets. Diabetes 37:1411-1418
79. Pakala SV, Chivetta M, Kelly CB, Katz JD 1999 In autoimmune diabetes the transition from benign to pernicious insulitis requires an islet cell response to tumor necrosis factor α. J Exp Med 189:1053-1062
80. Palombella V, Rando OJ, Goldberg AL, Maniatis T 1994 The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB. Cell 78:773-785
81. Quaaz F, Li M, Beg AA 1999 A critical role for the RelA subunit of nuclear factor κB in regulation of multiple immune-response genes and in Fas-induced cell death. J Exp Med 189:999-1004
82. Rabinovitch A 1998 An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus. Diabetes Metab Rev 14:129-151
83. Rabinovitch A, Skyler JS 1998 Prevention of type 1 diabetes. Med Clin N Am 82:739-755
84. Ramsdell F, Seaman MS, Miller RE, Tough TW, Alderson MR, Lynch DH 1994 gld/gld mice are unable to express a functional ligand for Fas. Eur J Immunol 24:928-933
85. Restifo NP 2000 Not so Fas: re-evaluating the mechanisms of immune privilege and tumor escape. Nat Med 6:493-495
86. Rieux-Laucat F, Le Deist F, Hivroz C, Roberts IA, Debatin KM, Fischer A, de Villartay JP 1995 Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268:1347-1349
87. Rudolph D, Yeh WC, Wakeham A, Rudolph B, Nallainathan D, Potter J, Elia AJ, Mak TW 2000 Severe liver degeneration and lack of NF-κB actvation in NEMO/IKKT-γ-deficient mice. Genes Dev 14:854-862
88. Schmid RM, Perkins ND, Duckett CS, Andrews PC, Nabel GJ 1991 Cloning of an NF-κB subunit which stimulates HIV transcription in synergy with p65. Nature 352:733-736
89. Sears C, Olesen J, Rubin D, Finley D, Maniatis T 1998 NF-κB p105 processing via the ubiquitin-proteasome pathway. J Biol Chem 273:1409-1419
90. Sha WC, Liou HC, Tuomanen EI, Baltimore D 1995 Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell 80:321-330
91. Smerdon RA, Peakman M, Hussain MJ, Alviggi L, Watkins PJ, Leslie RD, Vergani D 1993 Increase in simultaneous coexpression of naive and memory lymphocyte markers at diagnosis of IDDM. Diabetes 42:127-133
92. H transcription, and Ig class switching. J Immunol 156:183-191
93. Stephens LA, Thomas HE, Kay TW 1997 Protection of NIT-1 pancreatic beta-cells from immune attack by inhibition of NF-κB. J Autoimmunity 10:293-298
94. Suarez-Pinzon W, Sorensen O, Bleackley RC, Elliott JF, Rajotte RV, Rabinovitch A 1999 Beta-cell destruction in NOD mice correlates with Fas (CD95) expression on beta-cells and proinflammatory cytokine expression in islets. Diabetes 48:21-28
95. Sun SC, Ganchi PA, Beraud C, Ballard DW, Greene WC 1994 Autoregulation of the NF-κB transactivator RelA (p65) by multiple cytoplasmic inhibitors containing ankyrin motifs. Proc Natl Acad Sci USA 91:1346-1350
96. Takahashi T, Tanaka M, Brannan CI, Jenkins NA, Copeland NG, Suda T, Nagata S 1994 Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76:969-976
97. Takeda K, Takeuchi O, Tsujimura T, Itami S, Adachi O, Kawai T, Sanjo H, Yoshikawa K, Terada N, Akira S 1999 Limb and skin abnormalities in mice lacking IKKα [see comments]. Science 284:313-316
98. Tan TH, Huang GP, Sica A, Ghosh P, Young HA, Longo DL, Rice NR 1992 κB site dependent activation of the interleukin-2 receptor α-chain gene promoter by human c-Rel. Mol Cell Biol 12:4067-4075
99. Tanaka M, Fuentes ME, Yamaguchi K, Durnin MH, Dalrymple SA, Hardy KL, Goeddel DV 1999 Embryonic lethality, liver degeneration, and impaired NF-κB activation in IKK-β-deficient mice. Immunity 10:421-429
100. Thanos D, Maniatis T 1995 NF-κB: a lesson in family values. Cell 80:529-532
101. Thomas HE, Darwiche R, Corbett JA, Kay TW 1999 Evidence that beta cell death in the nonobese diabetic mouse is Fas independent. J Immunol 163:1562-1569
102. Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM 1996 Suppression of TNF-α-induced apoptosis by NF-κB. Science 274:787-789
103. Van Kaer L, Ashton-Rickardt PG, Eichelberger M, Gaczynska M, Nagashima K, Rock KL, Goldberg AL, Doherty PC, Tonegawa S 1994 Altered peptidase and viral-specific T cell response in LMP-2 mutant mice. Immunity 1:533-541
104. Verma IM, Stevenson EM, Schwarz DV, Antwerp S, Miyamoto S 1995 Rel/NF-κB/IκB family: intimate tales of association and dissociation. Genes Dev 9:2723-2735
105. Vidal-Puig A, Faustman DL 1994 Tolerance to peripheral tissue is transient and maintained by tissue specific class I expression. Transplant Proc 26:3314-3316
106. Vives-Pi M, Armengol MP, Alcaide L, Costa M, Somoza N, Vargas F, Jaraquemada D, Pujol-Borrell R 1996 Expression of transporter associated with antigen processing-1 in the endocrine cells of human pancreatic islets: effect of cytokines and evidence of hyperexpression in IDDM. Diabetes 45:779-788
107. Wakatsuki Y, Neurath MF, Max EE, Strober W 1994 The B cell-specific transcription factor BSAP regulates B cell proliferation. J Exp Med 179:1099-1108
108. Wallach D, Varfolomeev EE, Malinin NL, Goltsev YV, Kovalenko AV, Boldin MP 1999 Tumor necrosis factor receptor and Fas signaling mechanisms. Annu Rev Immunol 17:331-367
109. Wang CY, Mayo MW, Baldwin AS 1996 TNF- and cancer therapy-induced apoptosis potentiation by inhibition of NF-κB. Science 274:784-787
110. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S 1992 Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314-317
111. Watson ML, Rao JK, Gilkeson GS, Ruiz P, Eicher EM, Pisetsky DS, Matsuzawa A, Rochelle JM, Seldin MF 1992 Genetic analysis of MRL-lpr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci. J Exp Med 176:1645-1656
112. Weih F, Carrasco D, Durham SK, Barton DS, Rizzo CA, Ryseck RP, Lira SA, Bravo R 1995 Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/Rel family. Cell 80:331-340
113. Weringer EJ, Like AA 1988 Identification of T cell subsets and class I and class II antigen expression in islet grafts and pancreatic islets of diabetic BioBreeding/Worcester rats. Am J Pathol 132:292-303
114. Wong HK, Kammer GM, Dennis G, Tsokos GC 1999 Abnormal NF-κB activity in T lymphocytes from patients with systemic lupus erythematosus is associated with decreased p65-RelA protein expression. J Immunol 163:1682-1689
115. Wu J, Wilson J, He J, Xiang L, Schur PH, Mountz JD 1996a Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease. J Clin Invest 98:1107-1113
116. Wu M, Lee H, Bellas RE, Schauer SL, Arsura M, Katz D, FitzGerald MJ, Rothstein TL, Sherr DH, Sonenshein GE 1996b Inhibition of NF-κB/Rel induces apoptosis of murine B cells. EMBO J 15:4682-4690
117. Yan G, Fu Y, Faustman DL 1997 Reduced expression of Tap1 and Lmp2 antigen processing genes in the nonobese diabetic (NOD) mouse due to a mutation in their shared bidirectional promoter. J Immunol 159:3068-3080
118. Yang XD, Tisch R, Singer SM, Cao ZA, Liblau RS, Schreiber RD, McDevitt HO 1994 Effect of tumor necrosis factor a on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process. J Exp Med 180:995-1004